rs201192930
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_002386.4(MC1R):c.364G>A(p.Val122Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000495 in 1,607,638 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_002386.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MC1R | NM_002386.4 | c.364G>A | p.Val122Met | missense_variant | 1/1 | ENST00000555147.2 | NP_002377.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MC1R | ENST00000555147.2 | c.364G>A | p.Val122Met | missense_variant | 1/1 | 6 | NM_002386.4 | ENSP00000451605.1 | ||
ENSG00000198211 | ENST00000556922.1 | c.364G>A | p.Val122Met | missense_variant | 1/5 | 2 | ENSP00000451560.1 | |||
MC1R | ENST00000555427.1 | c.364G>A | p.Val122Met | missense_variant | 3/4 | 5 | ENSP00000451760.1 | |||
MC1R | ENST00000639847.1 | c.364G>A | p.Val122Met | missense_variant | 3/3 | 5 | ENSP00000492011.1 |
Frequencies
GnomAD3 genomes AF: 0.000526 AC: 80AN: 152210Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000825 AC: 202AN: 244804Hom.: 0 AF XY: 0.000893 AC XY: 119AN XY: 133192
GnomAD4 exome AF: 0.000491 AC: 715AN: 1455310Hom.: 1 Cov.: 33 AF XY: 0.000505 AC XY: 366AN XY: 724326
GnomAD4 genome AF: 0.000525 AC: 80AN: 152328Hom.: 1 Cov.: 33 AF XY: 0.000483 AC XY: 36AN XY: 74486
ClinVar
Submissions by phenotype
Melanoma, cutaneous malignant, susceptibility to, 5 Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
MC1R-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 15, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at